Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP

Executive Director, Biosafety Services, Advarra

Prior to joining Advarra, Daniel Eisenman served as Biosafety Officer at UNC Chapel Hill and the Medical University of South Carolina. Eisenman holds a PhD in Molecular Biology and Immunology from Augusta University, as well as various professional certifications in biological safety, including the Registered Biological Safety Professional (RBP) and Certified Biological Safety Professional (CBSP) certifications through the American Biological Safety Association (ABSA) and as a Specialist Microbiologist in Biological Safety (SM(NRCM)) through the American Society for Microbiology (ASM) National Registry of Certified Microbiologists (NRCM). He is also a devoted longtime educator, having taught microbiology at the undergraduate and graduate levels. Eisenman currently serves on the ABSA Owned Course Committee and is a regular speaker at clinical research conferences.

Latest Posts by Daniel Eisenman

mRNA and Its Role in Clinical Research

In the race to address the COVID-19 pandemic, researchers have worked tirelessly the past year...

Read More...

Does Warp Speed Vaccine Development and Testing Compromise Safety?

A common trope in sci-fi movies involves concerns about potentially smashing into uncharted objects while...

Read More...

Q&A – Study Startup Success for the New Generation of Genetically Engineered Vaccines

In a recent webinar, Advarra Executive Director of Biosafety Services Daniel Eisenman discussed the latest...

Read More...

Q&A Part 1 – Gene Therapy Research in the Age of COVID-19

In Advarra’s inaugural virtual symposium, experts from industry and academia met to discuss the unique...

Read More...

Q&A Part 2 – Gene Therapy Research in the Age of COVID-19

In Advarra’s inaugural virtual symposium, industry and academic experts discussed overcoming obstacles and optimizing study...

Read More...

Safety Precautions for Laboratory Research With COVID-19 Specimens

The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized...

Read More...

Infection Control and Biosafety in Gene Therapy Research

Gene therapy research has moved from the realm of science fiction to mainstream clinical research....

Read More...

Planning Gene Therapy Research? Plan for IBC Review

The completion of the human genome project and advances in genetic engineering have paved the...

Read More...
Login
Scroll to Top